Combination Therapy in AML and MDS

This chapter explores the potential of combination therapies in improving outcomes for patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS). They discuss the efficacy of combining two treatments, including an oral medication, based on an encouraging study. Ongoing studies that are investigating the combination of the oral medication with targeted therapies are also mentioned.